Prevention of laser arterial thrombus formation with unfractionated heparin. 1993

F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
Laboratoire d'Hématologie, Bordeaux, France.

A method to induce microthrombi in small mesenteric arteries (30-40 microns) has been developed to study platelet reactions and to investigate antithrombotic drugs. This model was used to evaluate the effect of Ca-heparin. Mesenteric lesions are induced in the vascular system of Wistar rats with an argon laser. The laser induced the formation of vessel wall lesion with damage of endothelial cells. Thrombi formed within seconds after the laser lesion and grew rapidly. Embolization began within a minute following the laser flash. Thrombus formation and embolization were repetitive phenomena. The administration of Ca-heparin at different dosages (0.5, 1.0 and 2.0 mg/kg) increases the number of laser injuries required to induce thrombus formation, and dose-dependently decreases the number of emboli and the duration of embolization. The highest dose injected (2.0 mg/kg) induced the strongest reduction in the number of emboli and duration of embolization.

UI MeSH Term Description Entries
D007834 Lasers An optical source that emits photons in a coherent beam. Light Amplification by Stimulated Emission of Radiation (LASER) is brought about using devices that transform light of varying frequencies into a single intense, nearly nondivergent beam of monochromatic radiation. Lasers operate in the infrared, visible, ultraviolet, or X-ray regions of the spectrum. Masers,Continuous Wave Lasers,Pulsed Lasers,Q-Switched Lasers,Continuous Wave Laser,Laser,Laser, Continuous Wave,Laser, Pulsed,Laser, Q-Switched,Lasers, Continuous Wave,Lasers, Pulsed,Lasers, Q-Switched,Maser,Pulsed Laser,Q Switched Lasers,Q-Switched Laser
D008297 Male Males
D008638 Mesenteric Arteries Arteries which arise from the abdominal aorta and distribute to most of the intestines. Arteries, Mesenteric,Artery, Mesenteric,Mesenteric Artery
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004617 Embolism Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream. Embolus,Embolisms
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
January 1992, VASA. Supplementum,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
March 1991, Blood,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
September 2010, Thrombosis research,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
February 1988, The British journal of surgery,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
December 1989, Wiener medizinische Wochenschrift (1946),
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
June 1998, Arteriosclerosis, thrombosis, and vascular biology,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
February 2011, Rinsho byori. The Japanese journal of clinical pathology,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
November 2006, The Journal of heart valve disease,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
October 2007, Nature clinical practice. Neurology,
F Doutremepuich, and O Aguejouf, and F Azougagh Oualane, and C Doutremepuich
January 2007, Likars'ka sprava,
Copied contents to your clipboard!